ORION THERAPEUTICS INC.

KNOXVILLE, TN · Founded 2022 · CIK 0001958173 · Biotech · Private

Customizable lipid nanoparticles for targeted RNA therapeutic delivery to specific tissues

Grants
$1.2M
1 award
Sector median: 1
Raised
$145K
2 Form D · Sep 2024
24 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$60,000
Private capital raisedForm D · SEC$85,000
Federal grantNational Science Foundation · Phase II · STTR Phase II: Multifunctional Lipid Nanoparticle Delivery System for Targeted Delivery of Vascular RNA Therapeutics$1,249,673
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2648ViroMissile, Inc.—$150K
2649Integrated Micro-Chromatography Systems, Inc.—$150K
2650SIDERO BIOSCIENCE, LLC—$145K
2651ORION THERAPEUTICS INC.—$145K
2652Finch Therapeutics, Inc.—$4.5M
2653TARTAN LLC—$130K
2654NEUIMMUNE, INC.—$125K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Richard FisherDirector · Executive Officer
  • Michael McCamanDirector · Executive Officer
  • Deidra MountainDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.